Shockwave C2+ Catheter Expands Utility of IVL in Calcified Coronary Arteries Shockwave C2+ is commercially available for the treatment of de novo coronary artery disease in Europe and select other ...
Patients treated by female physicians have lower mortality and readmission rates, a recent study found. The study, published April 23 in Annals of Internal Medicine, used a 20% random sample of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback